How to manage HGD in patients with Barrett Esophagus? HGD is associated with 30% risk of developing EAC. If HGD is confirmed by an expert GI pathologist, there is currently no agreement on the most appropriate management of these patients. Treatment options available to patients include intensive endoscopic surveillance with four-quadrant biopsies every 1 cm […]
How to manage HGD in Barrett Esophagus Read More »
How is LGD managed in patients with Barrett Esophagus? LGD must be confirmed on a repeat EGD within 6 months, and an expert GI pathologist is also required to review the biopsy samples before the initiation of annual endoscopic surveillance. Surveillance endoscopy continues until there is no dysplasia on two consecutive endoscopic examinations. Some experts
How is LGD managed in Barrett Esophagus Read More »
What is Barrett Esophagus (BE, metaplasia)? Is endoscopic screening and surveillance for BE necessary? BE is the development of specialized intestinal metaplasia (SIM) of the distal tubular esophagus, which has been identified as a premalignant precursor to EAC. The incidence of EAC is currently increasing at a rate greater than that of any other cancer
Is endoscopic screening and surveillance for Barrett Esophagus necessary Read More »
Endoscopic cancer screening of the esophagus is primarily undertaken for what two types of esophageal cancers? What risk factors are associated with these two types of cancers? Esophageal adenocarcinoma (EAC) is the most common type of esophageal cancer in the United States; it is increasing in prevalence and is highly associated with BE, gastroesophageal reflux
Risk factors for esophageal cancers Read More »
Why is endoscopic cancer screening and surveillance performed for GI cancers? GI cancers are annually reported as one of the most common causes of cancer death. Many if not all GI cancers begin on the mucosa and have well-defined premalignant lesions that are easily identified on endoscopy; examples include Barrett’s esophagus (BE) and colorectal adenomas.
Why is endoscopic cancer screening and surveillance performed for GI cancers Read More »
What is endoscopic cancer screening and surveillance? Endoscopic screening for premalignant or malignant conditions is the one-time application of a test to search for lesions in asymptomatic persons in the hope that an early diagnosis will have an effect on disease outcomes. Endoscopic surveillance is testing patients with known premalignant or malignant conditions repeatedly over time to
Endoscopic cancer screening and surveillance Read More »
Symptoms of pancreatitis, panniculitis, and polyarthritis (PPP) syndrome PPP syndrome is a systemic syndrome occurring in some patients with pancreatitis or pancreatic acinar cell carcinoma. Its clinical manifestations can be remembered by the following mnemonic: P = Pancreatitis A = Arthritis (60%) and arthralgias, usually of the ankles and knees (synovial fluid is typically noninflammatory and creamy
Symptoms of pancreatitis panniculitis and polyarthritis syndrome Read More »
